Материал: Клинические+рекомендации_ЛГ

5.Федеральный закон от 12.04.2010 № 61-ФЗ (ред. от 03.07.2016) «Об обращении лекарственных средств».

P. 67–119.

7.Малая медицинская энциклопедия. – М.: Медицинская энциклопедия. 1991–96 гг.

enc_medicine/28878/Синдром.

8.Андреева Н. С., Реброва О. Ю., Зорин Н. А. et al. Системы оценки достоверности научных доказательств и убедительности рекомендаций: сравнительная характеристика и перспективы унификации. Медицинские технологии. Оценка и выбор. – 2012. – №. 4. – С. 10–24.

9.Hoeper MM, Apitz C, Grünig E, Halank M, Ewert R, Kaemmerer H, Kabitz HJ, Kähler C, Klose H, Leuchte H, Ulrich S, Olsson KM, Distler O, Rosenkranz S, Ghofrani HA. Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018// Int J Cardiol. 2018.-272S.-P.37–45.

10.Galiè N, Channick RN, Frantz RP, Grünig E, Jing ZC, Moiseeva O, Preston IR, Pulido T, Safdar Z, Tamura Y, McLaughlin VV. Risk stratification and medical therapy of pulmonary arterial hypertension// Eur Respir J.-2019.-Vol.53.-N1.-pii:1801889.

11.Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019; 53: 1801913 [https://doi.org/10.1183/13993003.01913-2018.

12.Kovacs G, Berghold A, Scheidl S, et al. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 2009; 34(4): 888–894.

13.Callan P, Clark AL. Right heart catheterisation: indications and interpretation. Heart 2016; 102(2):147–157.

14.Hemnes AR, Zhao M, West J, et al. Critical genomic networks and vasoreactive variants in idiopathic pulmonary arterial hypertension// Am J Respir Crit Care Med.- 2016.-Vol. 194.- N4.-P.464–475.

116

15.Rosenzweig EB, Abman SH, Adatia I, et al. Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management// Eur Respir J.- 2019.- Vol. 53, N1 - 1801916.

16.McLaughlin VV, McGoon MD. Pulmonary arterial hypertension. Circulation. 2006; 114(13):1417–1431.

17.Hoeper MM, Ghofrani HA, Grünig E, Klose H, Olschewski H, Rosenkranz S. Pulmonary Hypertension. Dtsch Arztebl Int. 2017; 114(5):73–84.

18.Humbert M., Sitbon O., Chaouat A., Bertocchi M., Habib G., Gressin V., Yaici A., Weitzenblum E., Cordier J.F., Chabot F., Dromer C., Pison C., Reynaud-Gaubert M., Haloun A., Laurent M., Hachulla E., Simonneau G. Pulmonary arterial hypertension in

France: results from a national registry // Am J. Respir. Crit. Care Med. – 2006. –

Vol. 173. – N. 9. – P. 1023–1030.

19.Benza R.L., Miller D.P., Gomberg-Maitland M., Frantz R.P., Foreman A.J., Coffey C.S., Frost A., Barst R.J., Badesch D.B., Elliott C.G., Liou T.G., McGoon M.D. Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) // Circulation. – 2010. – Vol. 122. – N. 2. – P. 164–172.

20.Чазова И. Е., Архипова О. А., Мартынюк Т. В. Легочная артериальная гипертензия в России: анализ шестилетнего наблюдения по данным Национального регистра.

Терапевтический архив. 2019; 91 (1): 10–31.

21.Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP,

Goldring RM, Groves BM, Koerner SK, et al. Primary pulmonary hypertension.

A national prospective study. Ann Intern Med. 1987; 107(2):216–223.

22.Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaïci A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Cottin V, Degano B, Jaïs X, Montani D, Souza R, Simonneau

G. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 2010 Jul 13; 122(2):156– 163;

23.Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ,

Benza RL, Liou TG, Turner M, Giles S, Feldkircher K, Miller DP, McGoon MD. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010; 137(2):376–387.

117

24.Hoeper MM, Huscher D, Ghofrani HA, Delcroix M, Distler O, Schweiger C, Grunig E, Staehler G, Rosenkranz S, Halank M, Held M, Grohé C, Lange TJ, Behr J, Klose H,

Wilkens H, Filusch A, Germann M, Ewert R, Seyfarth HJ, Olsson KM, Opitz CF, Gaine SP, Vizza CD, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Pittrow D. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. Int J Cardiol. 2013; 168(2):871–880.

25.Ling Y, Johnson MK, Kiely DG, Condliffe R, Elliot CA, Gibbs JS, Howard LS, Pepke-

Zaba J, Sheares KK, Corris PA, Fisher AJ, Lordan JL, Gaine S, Coghlan JG, Wort SJ,

the pulmonary hypertension registry of the United Kingdom and Ireland.Am J Respir Crit Care Med. 2012; 186(8):790–796.

26.Rosenkranz S, Lang IM, Blindt R, Bonderman D, Bruch L, Diller GP, Felgendreher R, Gerges C, Hohenforst-Schmidt W, Holt S, Jung C, Kindermann I, Kramer T, Kübler WM, Mitrovic V, Riedel A, Rieth A, Schmeisser A, Wachter R, Weil J, Opitz CF. Pulmonary hypertension associated with left heart disease: Updated Recommendations of the Cologne Consensus Conference 2018.Int J Cardiol. 2018; 272S:53–62.

27.Mehra P, Mehta V, Sukhija R, Sinha AK, Gupta M, Girish MP, Aronow WS. Pulmonary hypertension in left heart disease.Arch Med Sci. 2019; 15(1):262–273.

28.Nathan SD, Barbera JA, Gaine SP, Harari S, Martinez FJ, Olschewski H, Olsson KM, Peacock AJ, Pepke-Zaba J, Provencher S, Weissmann N, Seeger W. Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J. 2019; 53(1). pii: 1801914.

29.Raghu G, Nathan SD, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Wells AU, Shao L, Zhou H, Henig N, Szwarcberg J, Gillies H, Montgomery AB, O'Riordan TG. Pulmonary hypertension in idiopathic pulmonary fibrosis with mild to moderate restriction. Eur Respir J 2015; 46(5): 1370–1377.

30. Shorr AF, Helman DL, Davies DB, Nathan SD. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J. 2005; 25(5):783–788.

31.Simonneau G, Torbicki A, Dorfmüller P, Kim N. The pathophysiology of chronic thromboembolic pulmonary hypertension. Eur Respir Rev 2017; 26(143): pii: 160112.

32.Pepke-Zaba J, Jansa P, Kim NH, Naeije R, Simonneau G. Chronic thromboembolic pulmonary hypertension: role of medical therapy// Eur Respir J.- 2013.-Vol.41.-N4.-985– 990.

118

33.Wilkens H, Konstantinides S, Lang IM, Bunck AC, Gerges M, Gerhardt F, Grgic A, Grohé C, Guth S, Held M, Hinrichs JB, Hoeper MM, Klepetko W, Kramm T, Krüger U, Lankeit M, Meyer BC, Olsson KM, Schäfers HJ, Schmidt M, Seyfarth HJ, Ulrich S, Wiedenroth CB, Mayer E. Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018. Int J Cardiol. 2018; 272S:69–78.

34.Чазова И. Е., Мартынюк Т. В., Валиева З. С., Наконечников С. Н., Недогода С. В.,

Саласюк А. С., Таран И. Н., Грацианская С. Е. Оценка бремени хронической тромбоэмболической легочной гипертензии в Российской Федерации.

Терапевтический архив, 2018.-N 9.-С.101–109.

35.Humbert M, Guignabert C, Bonnet S, Dorfmüller P, Klinger JR, Nicolls MR, Olschewski

AJ, Pullamsetti SS, Schermuly RT, Stenmark KR, Rabinovitch M. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J. 2019; 53(1). pii: 1801887.

36.Chaudhary KR, Taha M, Cadete VJ, Godoy RS, Stewart DJ. Proliferative Versus Degenerative Paradigms in Pulmonary Arterial Hypertension: Have We Put the Cart Before the Horse? Circ Res. 2017; 120(8):1237–1239.

37.Olschewski A, Berghausen EM, Eichstaedt CA, Fleischmann BK, Grünig E, Grünig G, Hansmann G, Harbaum L, Hennigs JK, Jonigk D, Kuebler WM, Kwapiszewska G,

Pullamsetti SS, Stacher E, Weissmann N, Wenzel D, Schermuly RT. Pathobiology, pathology and genetics of pulmonary hypertension: Update from the Cologne Consensus Conference 2018. Int J Cardiol. 2018; 272S:4–10.

38.Rosenkranz S., Gibbs J.S., Wachter R., De Marco T., Vonk-Noordegraaf A., Vachiéry J.L.

Left ventricular heart failure and pulmonary hypertension // Eur. Heart. J. – 2016. –

Vol. 37 – N. 12. – P. 942–954.

39.Авдеев С. Н. Легочная гипертензия при хронической обструктивной болезни легких // Системные гипертензии. – 2004. – Т. 1. – С. 5–11.

40.Klinger J.R. Group III Pulmonary Hypertension: Pulmonary Hypertension Associated with Lung Disease: Epidemiology, Pathophysiology, and Treatments // Cardiol. Clin. – 2016. – Vol. 34. – N. 3. – P. 413–433.

41.Awdish R, Cajigas H. Definition, epidemiology and registries of pulmonary hypertension. Heart Fail Rev 2016; 21 (3): 223–228.

119

42.Чазова И. Е., Архипова О. А., Валиева З. С., Наконечников С. Н., Мартынюк Т. В. Легочная гипертензия в России: первые результаты национального регистра. Терапевтический архив. 2014; 86(9):56–64.

43.Frost A, Badesch D, Gibbs JSR, Gopalan D, Khanna D, Manes A, Oudiz R, Satoh T, Torres F, Torbicki A. Diagnosis of pulmonary hypertension. Eur Respir J. 2019 Jan 24; 53(1). pii: 1801904.

44.Симакова М. А., Шлойдо Е. А., Зверев Д. А., Никитина А. В., Моисеева О. М. Рецидивирующее легочное кровотечение у беременной с идиопатической легочной артериальной гипертензией: клинический случай и обзор литературы //

Пульмонология. – 2014. – № 5. – С. 114–119.

45.Broberg C.S., Ujita M., Prasad S. et al. Pulmonary arterial thrombosis in Eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity// J Am Coll Cardiol.- 2007.-Vol. 50.-N7.-P.634–642.

46.Чазова И. Е., Авдеев С. Н., Царева Н. А., Волков А. В., Мартынюк Т. В., Наконечников С. Н. Клинические рекомендации по диагностике и лечению легочной гипертонии. Терапевтический архив 2014; №9: с.4–23.

47.Keeling D, Mackie I, Moore GW, Greer IA, Greaves M; British Committee for Standards in Haematology. Guidelines on the Investigation and Management of Antiphospholipid Syndrome. Br J Haematol. 2012;157(1):47-58.

48.Basyal В., Jarrett H., Barnett C.F. Pulmonary Hypertension in HIV. Canadian Journal of Cardiology 2019; 35: 288–298.

49.Bonderman D, Wexberg P, Martischnig AM, Heinzl H, Lang MB, Sadushi R, Skoro-Sajer N, Lang IM. A noninvasive algorithm to exclude pre-capillary pulmonary hypertension. Eur Respir J 2011; 37:1096–1103.

50.Rich JD, Thenappan T, Freed B, Patel AR, Thisted RA, Childers R, Archer SL. QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension. Int J Cardiol 2013; 167:669–676.;

51.Sun PY, Jiang X, Gomberg-Maitland M, Zhao QH, He J, Yuan P, Zhang R, Jing ZC. Prolonged QRS duration: a new predictor of adverse outcome in idiopathic pulmonary arterial hypertension. Chest 2012; 141:374–380.

52.Mercurio V, Peloquin G, Bourji KI et al. Pulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors, and clinical impact. Pulm Circ. 2018; 8(2):2045894018769874.

120